+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Drug Targets for Rational Design against Emerging Coronaviruses



Drug Targets for Rational Design against Emerging Coronaviruses



Infectious Disorders Drug Targets



The recent, fatal outbreak of the novel coronavirus strain in the Middle East highlights the real threat posed by this unique virus family. Neither pharmaceutical cures nor preventive vaccines are clinically available to fight against coronavirus associated syndromes, not to mention a lack of symptom soothing drugs. Development of treatment options is complicated by the unpredictable, recurring instances of cross-species viral transmission. The vastly distributing virus reservoir and the rapid rate of host-species exchange of coronavirus demands wide spectrum potency in an ideal therapeutic. Through summarizing the available information and progress in coronavirus research, this review provides a systematic assessment of the potential wide-spectrum features on the most popular drug targets including viral proteases, spike protein, RNA polymerases and editing enzymes as well as host-virus interaction pathways associated with coronaviruses.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 059633167

Download citation: RISBibTeXText

PMID: 23885693


Related references

Drug targets for rational design against emerging coronaviruses. Infectious Disorders Drug Targets 13(2): 116-127, 2013

Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy. Epilepsy Research. Supplement 11: 17-43, 1996

Granzymes as potential targets for rational drug design. Current Medicinal Chemistry 3(1): 37-46, 1996

Homology-based modelling of targets for rational drug design. Mini Reviews in Medicinal Chemistry 4(7): 793-804, 2004

Rational drug design and high-throughput techniques for RNA targets. Combinatorial Chemistry & High Throughput Screening 3(3): 219-234, 2000

Experiences with the shikimate-pathway enzymes as targets for rational drug design. Biochemical Society Transactions 31(Pt 3): 548-552, 2003

Big endothelin isoforms Molecular models as targets for rational drug design. Biophysical Journal 74(2 Part 2): A255, 1998

Crystal structures of coagulation serine proteinases as targets for rational drug design. Medicinal Chemistry Research 12(4-5): 239-240, 2003

Intracellular targets of antitumor therapy: an increased complexity in the rational drug design. Russian Chemical Bulletin 64(9): 2269-2272, 2015

The apoptosome: emerging insights and new potential targets for drug design. Pharmaceutical Research 25(4): 740-751, 2008

Multidrug resistance associated with altered topoisomerase II activity--topoisomerases II as targets for rational drug design. Journal of the National Cancer Institute 82(8): 638-639, 1990

Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design. Journal of Neuro-Oncology 139(2): 469-478, 2018

Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Science 9(7): 1274-1281, 2000

Bioinformatics and rational drug design: Tools for discovery and better understanding of biological targets and mode of action of drugs. Scandinavian Journal of Gastroenterology 37(Suppl. 236): 95-99, 2002

Peptidomimetic discovery and development Structure-based drug design, chemical diversity and emerging biological targets. Pharmaceutical Research (New York) 13(9 Suppl. ): S151, 1996